secwatch.observer — SEC 8-K summary
======================================

Issuer:     INTEGRATED BIOPHARMA INC (INBP)
CIK:        0001016504
Form:       8-K
Filed at:   2025-11-10T23:59:59+00:00
Accession:  0001437749-25-034091
Event type: earnings
Sentiment:  negative
Materiality: 0.50
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Integrated BioPharma Q1 revenue down 6.6% to $12.7M; net income $0.1M, EPS $0.00
--------------------------------------------------------------------------------

- Revenue $12.7M, down 6.6% from $13.6M YoY; gross profit $1.0M vs $1.4M.
- Net income $123K ($0.00 basic EPS) vs $259K ($0.01) in prior year quarter.
- Operating income $163K vs $490K YoY, driven by lower gross profit.
- Two largest customers in Contract Manufacturing = 87% of total revenue (85% in prior year).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925034091/0001437749-25-034091-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1016504/000143774925034091/inbp20251107_8k.htm
  HTML page:      https://secwatch.observer/filing/0001437749-25-034091

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer